Brief: Pharming Announces FDA Approval Of Joenja As First And Only Treatment Indicated For APDS

Pharming

24/03/2023 18:32

March 24 (Reuters) - Pharming Group NV  PHAR.AS :
    * PHARMING ANNOUNCES US FDA APPROVAL OF JOENJA® (LENIOLISIB)
AS
THE FIRST AND ONLY TREATMENT INDICATED FOR APDS
    * PHARMING GROUP NV - JOENJA IS EXPECTED TO LAUNCH IN US IN
EARLY
APRIL
    * PHARMING GROUP NV - EXPECTS THAT CHMP WILL ISSUE ITS
OPINION ON
MAA FOR LENIOLISIB IN SECOND HALF OF 2023

Source text for Eikon:  ID:nCNWbPLGBa 
Further company coverage:  PHAR.AS 

 ((Reuters.Briefs@thomsonreuters.com;))